Skip to main content
Figure 3 | BMC Health Services Research

Figure 3

From: Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China

Figure 3

Tornado diagram representing the net health benefit (QALYs, WTP=$11,034) determined by a one-way sensitivity analysis of combination therapy (ADV+LMV) vs. no treatment for LAM-resistant HBeAg-positive (A) and HBeAg-negative (B) chronic hepatitis B. The vertical line represents the base-case value for the net health benefit under WTP=$11,034.

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us